Arterys Cardio DL vs Tempus ECG-Low EF
AI Verdict
Choose Arterys Cardio DL if…
Choose Arterys Cardio DL if your primary need is advanced, efficient, and highly accurate analysis of cardiac MRI studies. This cloud-based AI solution is ideal for cardiologists and radiologists requiring automated ventricle segmentations, 4D Flow post-processing, and quantitative delayed enhancement to drastically reduce interpretation time and enhance diagnostic precision for complex cardiac imaging.
View Arterys Cardio DL →Choose Tempus ECG-Low EF if…
Choose Tempus ECG-Low EF if you need a rapid, AI-powered screening tool to identify patients at risk of low left ventricular ejection fraction (LVEF ≤40%) using standard 12-lead ECGs. This software is best suited for clinical settings like emergency medicine, internal medicine, or cardiology clinics where early detection and risk stratification for heart failure are crucial for patients 40 years or older.
View Tempus ECG-Low EF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Arterys Cardio DL | Tempus ECG-Low EF |
|---|---|---|
| Deployment | Cloud-based (SaaS), integrates with existing PACS or EHR, web-based zero-footprint viewer (Mac, PC, tablet, phone). [4, 7, 9, 13, 27] | Integrates with current ECG platforms and electronic health records (EHRs). |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Arterys Cardio DLArterys Cardio DL is cloud-based, offering rapid analysis (seconds vs. 30-60 minutes) and editable automated contours, which significantly streamlines workflow and enhances efficiency for complex cardiac MRI interpretations. Its vendor-agnostic compatibility and cloud deployment also suggest easier access and integration compared to software requiring integration into existing facility workflows.
Clinical Value
Tempus ECG-Low EFTempus ECG-Low EF leverages a widely available and inexpensive test (ECG) to identify patients at risk of low LVEF, a critical indicator for heart failure, potentially enabling earlier intervention for a broad patient population. While Arterys Cardio DL provides detailed MRI analysis, Tempus's ability to offer early risk stratification from a common test has a significant and widespread clinical impact.
Pricing & Value
TieBoth tools require contacting the vendor for pricing, which limits transparency and makes a direct cost comparison impossible. While both offer substantial clinical value in their respective domains, without specific pricing details, it's not possible to determine which provides better value for money.
Enterprise Readiness
Arterys Cardio DLBoth tools are FDA-cleared, HIPAA compliant, and offer BAAs, demonstrating strong foundational enterprise readiness. However, Arterys Cardio DL's cloud-based deployment and explicit 'vendor-agnostic compatibility' suggest greater flexibility and potentially simpler integration across diverse enterprise IT environments.
Innovation
Arterys Cardio DLArterys Cardio DL is described as 'the world's first internet platform for medical imaging' and the 'first technology to be cleared by the FDA that leverages cloud computing and deep learning in a clinical setting,' indicating a foundational innovation in medical imaging architecture. Its advanced features like 4D Flow and Quantitative Delayed Enhancement further highlight its innovative capabilities in complex MRI analysis.
Support & Docs
TieThe provided structured facts and web searches do not offer sufficient comparative detail on the quality, availability, or types of support and documentation for either tool. As both are FDA-cleared medical software, robust support and documentation are expected, but a definitive winner cannot be determined without more specific information.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Arterys Cardio DL | Tempus ECG-Low EF |
|---|---|---|
| Name | Arterys Cardio DL | Tempus ECG-Low EF |
| Company | ARTERYS | Tempus AI |
| Description | FDA-cleared, cloud-based AI software that provides automated, editable ventricle segmentations for cardiac MRI analysis, drastically reducing interpretation time and enhancing diagnostic accuracy. | FDA-cleared AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure. It provides a binary output to aid clinicians in further evaluation. |
| Primary Function | Automated, editable ventricle segmentations for cardiac MRI analysis | Analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) |
| Target Patient Population/Data | Cardiac MRI | Patients 40 years or older at risk of heart failure, using 12-lead ECG recordings |
Videos
Demos, reviews, and walkthroughs featuring Arterys Cardio DL and Tempus ECG-Low EF.